Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Red Bank, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Hepion Pharmaceuticals, Inc. has filed 675 SEC EDGAR filings since 08 Aug 2013

SEC filing history

Showing 176-200 of 675 matching filings.

Per page
25
Current page
8
DEF 14A File 001-36856

DEF 14A

Filing date
07 Sep 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36856

PRE 14A

Filing date
23 Aug 2021
Reporting date
03 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36856

DEFA14A

Filing date
25 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36856

FORM 8-K

Filing date
09 Jun 2021
Reporting date
09 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .